1. Home
  2. GNE vs SGMO Comparison

GNE vs SGMO Comparison

Compare GNE & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNE
  • SGMO
  • Stock Information
  • Founded
  • GNE 2011
  • SGMO 1995
  • Country
  • GNE United States
  • SGMO United States
  • Employees
  • GNE N/A
  • SGMO N/A
  • Industry
  • GNE Power Generation
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GNE Utilities
  • SGMO Health Care
  • Exchange
  • GNE Nasdaq
  • SGMO Nasdaq
  • Market Cap
  • GNE 421.6M
  • SGMO 488.2M
  • IPO Year
  • GNE N/A
  • SGMO 2000
  • Fundamental
  • Price
  • GNE $14.86
  • SGMO $1.13
  • Analyst Decision
  • GNE
  • SGMO Buy
  • Analyst Count
  • GNE 0
  • SGMO 5
  • Target Price
  • GNE N/A
  • SGMO $5.20
  • AVG Volume (30 Days)
  • GNE 74.0K
  • SGMO 10.5M
  • Earning Date
  • GNE 03-10-2025
  • SGMO 03-12-2025
  • Dividend Yield
  • GNE 2.01%
  • SGMO N/A
  • EPS Growth
  • GNE N/A
  • SGMO N/A
  • EPS
  • GNE 0.12
  • SGMO N/A
  • Revenue
  • GNE $427,221,000.00
  • SGMO $52,291,000.00
  • Revenue This Year
  • GNE N/A
  • SGMO N/A
  • Revenue Next Year
  • GNE N/A
  • SGMO $5.97
  • P/E Ratio
  • GNE $122.80
  • SGMO N/A
  • Revenue Growth
  • GNE 5.44
  • SGMO N/A
  • 52 Week Low
  • GNE $14.00
  • SGMO $0.30
  • 52 Week High
  • GNE $20.33
  • SGMO $3.18
  • Technical
  • Relative Strength Index (RSI)
  • GNE 46.70
  • SGMO 37.01
  • Support Level
  • GNE $14.54
  • SGMO $1.00
  • Resistance Level
  • GNE $15.70
  • SGMO $1.18
  • Average True Range (ATR)
  • GNE 0.36
  • SGMO 0.15
  • MACD
  • GNE -0.02
  • SGMO -0.04
  • Stochastic Oscillator
  • GNE 35.46
  • SGMO 13.84

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: